PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS
Medtronic Vascular, Inc. · Decision date Nov 5, 2026
What did the FDA decide?
The FDA recorded decision OK30 on 2026-11-05 for P060001/S060, a 30-Day Notice supplement to the premarket approval for the Protege GPS and Protege RX Carotid Stent Systems, submitted by Medtronic Vascular, Inc. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager or supplier.
The recorded statement covers approval of manufacturing and process validation changes for the delivery systems of the EverFlex and Protege GPS Self-Expanding Peripheral Stent Systems. This is a supplement-level decision about those delivery-system changes, not a new approval of the full stent systems. The source record does not describe the specific manufacturing steps, validation methods or supplier details, and it does not address clinical performance or labeling.
FDA approval order statement
approval for manufacturing and process validation changes for the delivery systems of the EverFlex and Protege GPS Self-Expanding Peripheral Stent Systems
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Nov 5, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060001/S060
- Regulatory pathway
- PMA supplement
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIM
- Decision code
- OK30
- Decision date
- Nov 5, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, carotid.
- Applicant
- Medtronic Vascular, Inc.
- Product code
- NIM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060001. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060001 · Original PMA
PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS
P060001/S060 received
Application receipt date recorded by FDA.
P060001/S059 · Related supplement
Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System
P060001/S060 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Vascular, Inc. | PMA approval | Jan 24, 2007 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA |
Explore the linked device profile
Other records with product code NIM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Contego Medical, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Contego Medical, Inc. | PMA approval | Oct 11, 2024 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 3033 Campus Dr., Plymouth, MN, 55441
Sources and methodology
- Original FDA record: P060001/S060
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

